Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) Net margin 2021–2025
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) net profit margin by fiscal year — reported net income divided by reported revenue.
-12.4%FY2025 · since FY2021: -55.8% → -12.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -12.4% | +5.6 pp |
| FY2024 | -18.1% | -103.2 pp |
| FY2023 | 85.2% | +1436.1 pp |
| FY2022 | -1350.9% | -1295.1 pp |
| FY2021 | -55.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice